FDA Inspection 1198059 — LifeStream Blood Bank

LifeStream Blood Bank — FEI 2077725

The FDA completed an inspection of LifeStream Blood Bank on February 8, 2023 in Riverside, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 8, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Riverside, CA (United States)